Showing 861 - 880 results of 1,182 for search '(( significant decrease decrease ) OR ( significant small decrease ))~', query time: 0.42s Refine Results
  1. 861

    Table 4_Acute effects of exercise snacks on postprandial glucose and insulin metabolism in adults with obesity: a systematic review and meta-analysis.docx by Yuanbo Chang (22654910)

    Published 2025
    “…Glucose tAUC and mean glucose showed non-significant downward trends. Mean insulin decreased (SMD = −0.54, 95% CI –0.97 to −0.10), albeit with high heterogeneity (I<sup>2</sup> = 76%). …”
  2. 862

    Image 5_Acute effects of exercise snacks on postprandial glucose and insulin metabolism in adults with obesity: a systematic review and meta-analysis.pdf by Yuanbo Chang (22654910)

    Published 2025
    “…Glucose tAUC and mean glucose showed non-significant downward trends. Mean insulin decreased (SMD = −0.54, 95% CI –0.97 to −0.10), albeit with high heterogeneity (I<sup>2</sup> = 76%). …”
  3. 863

    Table 1_Acute effects of exercise snacks on postprandial glucose and insulin metabolism in adults with obesity: a systematic review and meta-analysis.docx by Yuanbo Chang (22654910)

    Published 2025
    “…Glucose tAUC and mean glucose showed non-significant downward trends. Mean insulin decreased (SMD = −0.54, 95% CI –0.97 to −0.10), albeit with high heterogeneity (I<sup>2</sup> = 76%). …”
  4. 864

    Table 3_Acute effects of exercise snacks on postprandial glucose and insulin metabolism in adults with obesity: a systematic review and meta-analysis.docx by Yuanbo Chang (22654910)

    Published 2025
    “…Glucose tAUC and mean glucose showed non-significant downward trends. Mean insulin decreased (SMD = −0.54, 95% CI –0.97 to −0.10), albeit with high heterogeneity (I<sup>2</sup> = 76%). …”
  5. 865

    Image 3_Acute effects of exercise snacks on postprandial glucose and insulin metabolism in adults with obesity: a systematic review and meta-analysis.pdf by Yuanbo Chang (22654910)

    Published 2025
    “…Glucose tAUC and mean glucose showed non-significant downward trends. Mean insulin decreased (SMD = −0.54, 95% CI –0.97 to −0.10), albeit with high heterogeneity (I<sup>2</sup> = 76%). …”
  6. 866

    Image 2_Acute effects of exercise snacks on postprandial glucose and insulin metabolism in adults with obesity: a systematic review and meta-analysis.pdf by Yuanbo Chang (22654910)

    Published 2025
    “…Glucose tAUC and mean glucose showed non-significant downward trends. Mean insulin decreased (SMD = −0.54, 95% CI –0.97 to −0.10), albeit with high heterogeneity (I<sup>2</sup> = 76%). …”
  7. 867

    Table 6_Acute effects of exercise snacks on postprandial glucose and insulin metabolism in adults with obesity: a systematic review and meta-analysis.docx by Yuanbo Chang (22654910)

    Published 2025
    “…Glucose tAUC and mean glucose showed non-significant downward trends. Mean insulin decreased (SMD = −0.54, 95% CI –0.97 to −0.10), albeit with high heterogeneity (I<sup>2</sup> = 76%). …”
  8. 868

    Table 2_Acute effects of exercise snacks on postprandial glucose and insulin metabolism in adults with obesity: a systematic review and meta-analysis.docx by Yuanbo Chang (22654910)

    Published 2025
    “…Glucose tAUC and mean glucose showed non-significant downward trends. Mean insulin decreased (SMD = −0.54, 95% CI –0.97 to −0.10), albeit with high heterogeneity (I<sup>2</sup> = 76%). …”
  9. 869

    Image 4_Acute effects of exercise snacks on postprandial glucose and insulin metabolism in adults with obesity: a systematic review and meta-analysis.pdf by Yuanbo Chang (22654910)

    Published 2025
    “…Glucose tAUC and mean glucose showed non-significant downward trends. Mean insulin decreased (SMD = −0.54, 95% CI –0.97 to −0.10), albeit with high heterogeneity (I<sup>2</sup> = 76%). …”
  10. 870

    Table 5_Acute effects of exercise snacks on postprandial glucose and insulin metabolism in adults with obesity: a systematic review and meta-analysis.docx by Yuanbo Chang (22654910)

    Published 2025
    “…Glucose tAUC and mean glucose showed non-significant downward trends. Mean insulin decreased (SMD = −0.54, 95% CI –0.97 to −0.10), albeit with high heterogeneity (I<sup>2</sup> = 76%). …”
  11. 871

    Image 1_Acute effects of exercise snacks on postprandial glucose and insulin metabolism in adults with obesity: a systematic review and meta-analysis.pdf by Yuanbo Chang (22654910)

    Published 2025
    “…Glucose tAUC and mean glucose showed non-significant downward trends. Mean insulin decreased (SMD = −0.54, 95% CI –0.97 to −0.10), albeit with high heterogeneity (I<sup>2</sup> = 76%). …”
  12. 872

    Data Sheet 1_Lack of association between genetic variations in CYP3A5 and blood pressure or hypertension risk in the UK biobank.pdf by Pia Leibold (21390134)

    Published 2025
    “…</p>Discussion:<p>While some associations were statistically significant, the small effect sizes and lack of associations observed in the whole UK Biobank population suggest that CYP3A5 variation likely has no impact on blood pressure related phenotypes in a general population. …”
  13. 873

    Table 1_Effect of a mindfulness-based cognitive behavior therapy intervention on occupational burnout among school teachers.docx by Netra Raj Paudel (20610806)

    Published 2025
    “…The virtual MB-CBT intervention showed no significant impact on reducing burnout. Nonetheless, small reductions in burnout were observed in both groups.…”
  14. 874

    Supplementary Tables S1 and S2 by Thomas Clanton (9323303)

    Published 2025
    “…However, both plasma-free and plasma-containing buffer induced small but significant increases in secretion of several cytokines over the sample collection period. …”
  15. 875

    Table 1_A case report: enhanced somatostatin receptor expression in metastatic pancreatic neuroendocrine tumor following everolimus therapy.pdf by Pei Zhang (232846)

    Published 2025
    “…In January 2024, everolimus therapy was started, resulting in a partial response by April 2024, with a significant reduction in liver metastases. Due to small intestinal ulcers, the dose of everolimus was reduced in August 2024. …”
  16. 876

    Image 2_A case report: enhanced somatostatin receptor expression in metastatic pancreatic neuroendocrine tumor following everolimus therapy.pdf by Pei Zhang (232846)

    Published 2025
    “…In January 2024, everolimus therapy was started, resulting in a partial response by April 2024, with a significant reduction in liver metastases. Due to small intestinal ulcers, the dose of everolimus was reduced in August 2024. …”
  17. 877

    Table 2_A case report: enhanced somatostatin receptor expression in metastatic pancreatic neuroendocrine tumor following everolimus therapy.pdf by Pei Zhang (232846)

    Published 2025
    “…In January 2024, everolimus therapy was started, resulting in a partial response by April 2024, with a significant reduction in liver metastases. Due to small intestinal ulcers, the dose of everolimus was reduced in August 2024. …”
  18. 878

    Data Sheet 1_Integrated computational and experimental identification of N-[(1H-1,2,4-triazol-3-yl)phenyl]-1-(1H-pyrazolo[3,4-b]pyridin-3-yl)methanamide as a potent and selective T... by Xinxin Ying (21507500)

    Published 2025
    “…<p>Non-small cell lung cancer (NSCLC) remains a significant clinical challenge, necessitating exploration of novel therapeutic targets such as TIM-3. …”
  19. 879

    Image 1_A case report: enhanced somatostatin receptor expression in metastatic pancreatic neuroendocrine tumor following everolimus therapy.pdf by Pei Zhang (232846)

    Published 2025
    “…In January 2024, everolimus therapy was started, resulting in a partial response by April 2024, with a significant reduction in liver metastases. Due to small intestinal ulcers, the dose of everolimus was reduced in August 2024. …”
  20. 880

    Image_1_Impact of fat intake on [18F]AlF-NOTA-FAPI-04 uptake in normal abdominal organs.TIF by Jiashun Dai (20137596)

    Published 2024
    “…In the subgroup analysis of patients who underwent paired [<sup>18</sup>F]FDG and [<sup>18</sup>F]FAPI PET/CT scans, the <sup>18</sup>F-FAPI uptake of liver and small intestine was significantly lower than the <sup>18</sup>F-FDG uptake in both the treated group and the control group (p < 0.001).…”